Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Since 2012, No Shortage Of Variety In US OTC Switches While Short Of Chronic Conditions

Jun 30 2022

• By Malcolm Spicer

• Source: Shutterstock

Related Content

FDA Considers “New Paradigm” To Facilitate Third Class Of Drugs

Feb 27 2012

Xyzal Switch Extends Sanofi Into OTC 24-Hour Children's Antihistamine

Feb 02 2017

Bausch + Lomb’s First Results Look Familiar

Jun 08 2022

Dual Rx/OTC Status In US ‘Additional Condition’ Switch Proposal: Necessary Or Questionable?

Jun 30 2022

Perrigo Debuts On US National Brand Stage With OTC Switch Approval For Nasonex 24HR Allergy

Mar 17 2022

Alcaftadine Eye Drops For Allergies Available OTC In US With Allergan’s Lastacaft Launch

Mar 15 2022

Newly Approved OTC Eye Drop Could Boost Valeant Turnaround Outlook

Dec 29 2017

GSK's Flonase Sensimist (Veramyst) Switches Name On Way To OTC

Aug 16 2016

Pfizer Expects OTC <em>Nexium</em> Will Launch With Market Exclusivity

Mar 29 2014

Light Still On For Switches After Pfizer Pulls Plug On OTC <em>Lipitor</em>

Aug 03 2015

<em>Flonase</em> Switch Approved, Branded Nasal Allergy Spray Market Will Grow In 2015

Jul 24 2014

FDA Mulls Approach To Switches In Context Of Galderma's Acne Drug OTC Bid

Apr 20 2016

Galderma Pioneers NDA Path Into OTC Acne Treatment Market

Jul 11 2016

Oxytrol For Women Gets OTC Green Light As Rare First-In-Class Switch

Jan 28 2013

<em>Rhinocort</em> Switch Makes Three In OTC Intranasal Corticosteroid Market

Mar 26 2015

Sanofi’s <em>Nasacort</em> First-In-Class Switch Receives FDA Approval

Oct 11 2013

Switch Paradigm Change Sees Long Road, Breeds Questions

Mar 19 2012

<em>Plan B One-Step</em> Goes OTC, With Three-Year Exclusivity, Lower Age Limit

May 06 2013

Pataday Switch Approval Dilates Eye Drop Category As Alcon's OTC Sales Driver

Feb 20 2020

In Latest US OTC Switch, Ivermectin 0.5% Lice Treatment Becomes Fully Nonprescription

Oct 27 2020

OTC Allergy Switch Approved For Bayer In US

Jun 17 2021

Perrigo's OTC Core Could Expand To Include National Brands

Aug 10 2018

Related Companies

Merck & Co., Inc.

Sanofi

Johnson & Johnson

Pfizer Inc.

Bausch Health Companies Inc.

Bayer AG

Allergan plc

Perrigo Company PLC

Additional Topics

International United States US States FDA Prescription To OTC Switch Policy Advertising, Marketing & Sales Business Strategies Commercial Companies Compliance Consumer Distribution Drug Approval Standards Drug Review Drug Safety Guidance Documents Ingredients Manufacturing OTC Drugs Politics Regulation Retail

More from Rx-to-OTC Switch

More from Health

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window